C. elegans VAV-1 is a guanine nucleotide exchange factor (GEF) for Rho/Rac family GTPases and is homologous to the mammalian Vav proto-oncogenes. We found previously that VAV-1 regulates a variety of rhythmic activities in C. elegans, including pharyngeal pumping, ovulation and fertilization, and the defecation cycle, but its role in locomotion has remained unexplored. Interestingly, we have found that
vav-1 null animals display an elevated rate of locomotion and are hypersensitive to aldicarb (an acetylcholine esterase inhibitor), indicating heightened nervous system activity. The aldicarb hypersensitivity observed in
vav-1 mutants is rescued by pan-neural expression of VAV-1, and using further pharmacological assays, we have shown that this hypersensitivity is not due to altered response of
vav-1 mutant muscle cells to acetylcholine. Together, these data indicate that VAV-1 inhibits locomotion through a nervous system mechanism. Remarkably, Vav3 knockout mice are known to exhibit sympathetic nervous system hyperactivity, suggesting a conserved role of Vav proteins in negatively regulating nervous system activity, but the mechanism by which this regulation occurs is not fully understood (1-3). Since VAV-1 is known to be upstream of regulators of nervous system development (e.g. Rho/Rac GTPases), and impaired GABAergic neuron function can lead to aldicarb hypersensitivity, we examined the structure and function of GABA neurons by a combination of cell biological and pharmacological approaches. These analyses showed that both the development and function of GABA-releasing neurons is normal. To identify the cells that express
vav-1 and gain insight into the neural circuit that regulates locomotion, we have analyzed
vav-1 reporter expression in vivo and found that VAV-1 is expressed in a subset of neurons in the head ganglia of the worm, and highly expressed in the ALA neuron. Interestingly, the only known function of the ALA neuron is to regulate behavioral quiescence, the quantification of which is the rate of locomotion (4). We intend to elucidate the mechanism responsible for the control of locomotion by VAV-1 by determining the requirement of VAV-1 in the ALA neuron, as well as investigating the participation of VAV-1 in signaling pathways active in this cell. 1. Sauzeau et al. (2006). Nat. Med. 12, 841-845 2. Sauzeau et al. (2010). Mol Biol Cell. 21, 4251-63 3. Quevedo C. (2010). 15, 1125-39 4. Van Buskirk, C. and Sternberg, P.W. (2007) Nat. Neurosci. 10, 1300-07.